ITRM insider buying and SEC filings, explained
Iterum Therapeutics plc · CIK 1659323
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Nov 18, 2025 | Purchase (code P) | Michael W. Dunne (Director) bought 6,000 shares at $0.3700 ($2K), reported as a purchase (code P). Holdings up 3% to 241,001 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 20, 2025 |
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ITRM in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.